CeGaT Revolutionizes Exome Diagnostics with Genome-wide CNV Analysis CeGaT Revolutionizes Exome Diagnostics with Genome-wide CNV AnalysisNovember 16, 2023|
CeGaT and Twist Bioscience Launch RNA Fusion Panel to Advance Oncology and Precision Medicine Research CeGaT and Twist Bioscience Launch RNA Fusion Panel to Advance Oncology and Precision Medicine ResearchJune 1, 2023|
CeGaT Is One of the First Companies Worldwide to Receive the Most Powerful Sequencing Platform NovaSeq™ X Plus CeGaT Is One of the First Companies Worldwide to Receive the Most Powerful Sequencing Platform NovaSeq™ X PlusMarch 14, 2023|
Illumina NovaSeq™ X: CeGaT is One of the First Companies to Order Illumina’s Brand New Sequencer Illumina NovaSeq™ X: CeGaT is One of the First Companies to Order Illumina’s Brand New SequencerSeptember 29, 2022|
CeGaT Breaks Ground for Modern Annex Building at Tübingen Technology Park CeGaT Breaks Ground for Modern Annex Building at Tübingen Technology ParkOctober 26, 2021|